SHP2 is required for BCR-ABL1-induced hematologic neoplasia

SHP2 is required for BCR-ABL1-induced hematologic neoplasia Leukemia advance online publication, September 5 2017. doi:10.1038/leu.2017.250 Authors: S Gu, A Sayad, G Chan, W Yang, Z Lu, C Virtanen, R A Van Etten & B G Neel
Source: Leukemia - Category: Hematology Authors: Source Type: research
More News: Hematology | Leukemia